1. Home
  2. MNDO vs CRVO Comparison

MNDO vs CRVO Comparison

Compare MNDO & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

N/A

Current Price

$0.86

Market Cap

18.4M

Sector

Technology

ML Signal

N/A

Logo CervoMed Inc.

CRVO

CervoMed Inc.

N/A

Current Price

$1.41

Market Cap

21.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MNDO
CRVO
Founded
1995
2001
Country
Israel
United States
Employees
N/A
15
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.4M
21.5M
IPO Year
2000
2011

Fundamental Metrics

Financial Performance
Metric
MNDO
CRVO
Price
$0.86
$1.41
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
★ $15.00
AVG Volume (30 Days)
34.0K
★ 310.6K
Earning Date
11-20-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $4,006,510.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$525.01
P/E Ratio
$8.57
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.85
$1.46
52 Week High
$1.29
$10.00

Technical Indicators

Market Signals
Indicator
MNDO
CRVO
Relative Strength Index (RSI) 33.32 22.17
Support Level $0.85 N/A
Resistance Level $1.08 $3.86
Average True Range (ATR) 0.03 0.17
MACD -0.00 -0.07
Stochastic Oscillator 5.69 12.72

Price Performance

Historical Comparison
MNDO
CRVO

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About CRVO CervoMed Inc.

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Share on Social Networks: